About the bill
- Full Title
To amend the Public Health Service Act to eliminate the incentives that lead to increased prices and utilization of clinical laboratory diagnostic testing services and other ancillary health services.
The bill’s title was written by its sponsor.
Read CRS Summary >
Mar 2, 1994
This is the first step in the legislative process.
Read Text »
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 3939”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
21 cosponsors (14D, 7R)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 3939 — 103rd Congress: Ethics in Billing Act. Retrieved from https://www.govtrack.us/congress/bills/103/hr3939
“H.R. 3939 — 103rd Congress: Ethics in Billing Act.” www.GovTrack.us. 1994. February 6, 2016 <https://www.govtrack.us/congress/bills/103/hr3939>
|title=H.R. 3939 (103rd)
|accessdate=February 6, 2016
|author=103rd Congress (1994)
|date=March 2, 1994
|quote=Ethics in Billing Act